These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 30927586)
1. Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos. Farooq M; Sharma A; Almarhoon Z; Al-Dhfyan A; El-Faham A; Taha NA; Wadaan MAM; Torre BG; Albericio F Bioorg Chem; 2019 Jun; 87():457-464. PubMed ID: 30927586 [TBL] [Abstract][Full Text] [Related]
2. Di- and tri-substituted s-triazine derivatives: Synthesis, characterization, anticancer activity in human breast-cancer cell lines, and developmental toxicity in zebrafish embryos. El-Faham A; Farooq M; Almarhoon Z; Alhameed RA; Wadaan MAM; de la Torre BG; Albericio F Bioorg Chem; 2020 Jan; 94():103397. PubMed ID: 31706684 [TBL] [Abstract][Full Text] [Related]
3. The Antiproliferative and Apoptotic Effect of a Novel Synthesized Malebari AM; Abd Alhameed R; Almarhoon Z; Farooq M; Wadaan MAM; Sharma A; de la Torre BG; Albericio F; El-Faham A Molecules; 2021 Feb; 26(4):. PubMed ID: 33671801 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity. H Al Rasheed HHA; M Malebari AM; A Dahlous KA; El-Faham A Molecules; 2020 Jun; 25(11):. PubMed ID: 32545272 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, antitumor evaluation and microarray study of some new pyrazolo[3,4-d][1,2,3]triazine derivatives. Nasr T; Bondock S; Youns M; Fayad W; Zaghary W Eur J Med Chem; 2017 Dec; 141():603-614. PubMed ID: 29107422 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines. Mojzych M; Šubertová V; Bielawska A; Bielawski K; Bazgier V; Berka K; Gucký T; Fornal E; Kryštof V Eur J Med Chem; 2014 May; 78():217-24. PubMed ID: 24681986 [TBL] [Abstract][Full Text] [Related]
7. The activity of pyrazolo[4,3- Szymanowska A; Radomska D; Czarnomysy R; Mojzych M; Kotwica-Mojzych K; Bielawski K; Bielawska A J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2343352. PubMed ID: 38700244 [TBL] [Abstract][Full Text] [Related]
8. Heterocyclization of 2-(2-phenylhydrazono)cyclohexane-1,3-dione to Synthesis Thiophene, Pyrazole and 1,2,4-triazine Derivatives with Anti-Tumor and Tyrosine Kinase Inhibitions. Mohareb RM; Alwan ES Anticancer Agents Med Chem; 2020; 20(10):1209-1220. PubMed ID: 32156245 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives. Mojzych M; Tarasiuk P; Karczmarzyk Z; Juszczak M; Rzeski W; Fruzinski A; Wozny A Med Chem; 2018; 14(1):53-59. PubMed ID: 29065838 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel 1,3,4-trisubstituted pyrazole derivatives as potential chemotherapeutic agents for hepatocellular carcinoma. Harras MF; Sabour R Bioorg Chem; 2018 Aug; 78():149-157. PubMed ID: 29567429 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and antiproliferative activity evaluation of a series of pyrrolo[2,1-f][1,2,4]triazine derivatives. Xiang HY; Chen YH; Wang Y; Zhang X; Ding J; Meng LH; Yang CH Bioorg Med Chem Lett; 2020 Jun; 30(12):127194. PubMed ID: 32317209 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors. Kothayer H; Spencer SM; Tripathi K; Westwell AD; Palle K Bioorg Med Chem Lett; 2016 Apr; 26(8):2030-4. PubMed ID: 26965855 [TBL] [Abstract][Full Text] [Related]
13. Quinazoline clubbed 1,3,5-triazine derivatives as VEGFR2 kinase inhibitors: design, synthesis, docking, in vitro cytotoxicity and in ovo antiangiogenic activity. Pathak P; Shukla PK; Kumar V; Kumar A; Verma A Inflammopharmacology; 2018 Dec; 26(6):1441-1453. PubMed ID: 29663100 [TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, Docking Studies and Molecular Dynamics Simulation of New 1,3,5-Triazine Derivatives as Anticancer Agents Selectively Targeting Pancreatic Adenocarcinoma (Capan-1). Asghar S; Hameed S; Al-Masoudi NA; Saeed B; Shtaiwi A Chem Biodivers; 2024 May; 21(5):e202400112. PubMed ID: 38606640 [TBL] [Abstract][Full Text] [Related]
16. 1,3,5-Triazine-azole Hybrids and their Anticancer Activity. Guo H; Diao QP Curr Top Med Chem; 2020; 20(16):1481-1492. PubMed ID: 32156236 [TBL] [Abstract][Full Text] [Related]
17. Review of the Synthesis and Anticancer Properties of Pyrazolo[4,3- Bernat Z; Szymanowska A; Kciuk M; Kotwica-Mojzych K; Mojzych M Molecules; 2020 Aug; 25(17):. PubMed ID: 32872493 [TBL] [Abstract][Full Text] [Related]
18. Antitumor Activity of s-Triazine Derivatives: A Systematic Review. Dai Q; Sun Q; Ouyang X; Liu J; Jin L; Liu A; He B; Fan T; Jiang Y Molecules; 2023 May; 28(11):. PubMed ID: 37298753 [TBL] [Abstract][Full Text] [Related]
19. In vitro cytotoxicity of imidazolyl-1,3,5-triazine derivatives. Yaguchi S; Izumisawa Y; Sato M; Nakagane T; Koshimizu I; Sakita K; Kato M; Yoshioka K; Sakato M; Kawashima S Biol Pharm Bull; 1997 Jun; 20(6):698-700. PubMed ID: 9212994 [TBL] [Abstract][Full Text] [Related]
20. SARs of a novel series of s-triazine compounds targeting vimentin to induce methuotic phenotype. Zhang L; Qu Z; Wu J; Yao S; Zhang Q; Zhang T; Mo L; Yao Q; Xu Y; Chen R Eur J Med Chem; 2021 Mar; 214():113188. PubMed ID: 33550185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]